119 related articles for article (PubMed ID: 10784387)
21. Identification of novel cryptic translocations involving IGH in B-cell non-Hodgkin's lymphomas.
Gozzetti A; Davis EM; Espinosa R; Fernald AA; Anastasi J; Le Beau MM
Cancer Res; 2002 Oct; 62(19):5523-7. PubMed ID: 12359763
[TBL] [Abstract][Full Text] [Related]
22. Loss- and gain-of-function mutations reveal an important role of BSAP (Pax-5) at the start and end of B cell differentiation.
Morrison AM; Nutt SL; Thévenin C; Rolink A; Busslinger M
Semin Immunol; 1998 Apr; 10(2):133-42. PubMed ID: 9618759
[TBL] [Abstract][Full Text] [Related]
23. Lack of PAX5 rearrangements in lymphoplasmacytic lymphomas: reassessing the reported association with t(9;14).
Cook JR; Aguilera NI; Reshmi-Skarja S; Huang X; Yu Z; Gollin SM; Abbondanzo SL; Swerdlow SH
Hum Pathol; 2004 Apr; 35(4):447-54. PubMed ID: 15116325
[TBL] [Abstract][Full Text] [Related]
24. Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas.
Bertrand P; Bastard C; Maingonnat C; Jardin F; Maisonneuve C; Courel MN; Ruminy P; Picquenot JM; Tilly H
Leukemia; 2007 Mar; 21(3):515-23. PubMed ID: 17230227
[TBL] [Abstract][Full Text] [Related]
25. Identification of IGHCδ-BACH2 fusion transcripts resulting from cryptic chromosomal rearrangements of 14q32 with 6q15 in aggressive B-cell lymphoma/leukemia.
Kobayashi S; Taki T; Chinen Y; Tsutsumi Y; Ohshiro M; Kobayashi T; Matsumoto Y; Kuroda J; Horiike S; Nishida K; Taniwaki M
Genes Chromosomes Cancer; 2011 Apr; 50(4):207-16. PubMed ID: 21319257
[TBL] [Abstract][Full Text] [Related]
26. Involvement of BCL6 in chromosomal aberrations affecting band 3q27 in B-cell non-Hodgkin lymphoma.
Chaganti SR; Chen W; Parsa N; Offit K; Louie DC; Dalla-Favera R; Chaganti RS
Genes Chromosomes Cancer; 1998 Dec; 23(4):323-7. PubMed ID: 9824205
[TBL] [Abstract][Full Text] [Related]
27. Molecular cytogenetic characterization of t(14;19)(q32;p13), a new recurrent translocation in B cell malignancies.
Micci F; Panagopoulos I; Tjønnfjord GE; Kolstad A; Delabie J; Beiske K; Heim S
Virchows Arch; 2007 May; 450(5):559-65. PubMed ID: 17406891
[TBL] [Abstract][Full Text] [Related]
28. MUC1 is activated in a B-cell lymphoma by the t(1;14)(q21;q32) translocation and is rearranged and amplified in B-cell lymphoma subsets.
Dyomin VG; Palanisamy N; Lloyd KO; Dyomina K; Jhanwar SC; Houldsworth J; Chaganti RS
Blood; 2000 Apr; 95(8):2666-71. PubMed ID: 10753849
[TBL] [Abstract][Full Text] [Related]
29. Non-IG aberrations of FOXP1 in B-cell malignancies lead to an aberrant expression of N-truncated isoforms of FOXP1.
Rouhigharabaei L; Finalet Ferreiro J; Tousseyn T; van der Krogt JA; Put N; Haralambieva E; Graux C; Maes B; Vicente C; Vandenberghe P; Cools J; Wlodarska I
PLoS One; 2014; 9(1):e85851. PubMed ID: 24416450
[TBL] [Abstract][Full Text] [Related]
30. Detection of a t(4;14)(p16;q32) in two cases of lymphoma showing both the immunophenotype of chronic lymphocytic leukemia.
Bacher U; Haferlach T; Schnittger S; Weiss T; Burkhard O; Bechtel B; Kern W; Haferlach C
Cancer Genet Cytogenet; 2010 Jul; 200(2):170-4. PubMed ID: 20620602
[TBL] [Abstract][Full Text] [Related]
31. Translocation t(9;14)(p13;q32) in cases of splenic marginal zone lymphoma.
Baró C; Salido M; Domingo A; Granada I; Colomo L; Serrano S; Solé F
Haematologica; 2006 Sep; 91(9):1289-91. PubMed ID: 16956840
[TBL] [Abstract][Full Text] [Related]
32. A case of primary splenic large cell lymphoma with a t(9;14)(p13;q32).
Kawakami K; Amakawa R; Miyanishi S; Okumura A; Hayashi T; Kurata M; Ohno H; Ohno Y; Fukuhara S
Int J Hematol; 1998 Feb; 67(2):191-8. PubMed ID: 9631587
[TBL] [Abstract][Full Text] [Related]
33. Molecular-cytogenetic characterization of non-Hodgkin's lymphoma with double and cryptic translocations of the immunoglobulin heavy chain gene.
Kanda-Akano Y; Nomura K; Fujita Y; Horiike S; Nishida K; Nagai M; Miura I; Nakamura S; Seto M; Iida S; Ueda R; Taniwaki M
Leuk Lymphoma; 2004 Aug; 45(8):1559-67. PubMed ID: 15370207
[TBL] [Abstract][Full Text] [Related]
34. Cyclin D3 is a target gene of t(6;14)(p21.1;q32.3) of mature B-cell malignancies.
Sonoki T; Harder L; Horsman DE; Karran L; Taniguchi I; Willis TG; Gesk S; Steinemann D; Zucca E; Schlegelberger B; Solé F; Mungall AJ; Gascoyne RD; Siebert R; Dyer MJ
Blood; 2001 Nov; 98(9):2837-44. PubMed ID: 11675358
[TBL] [Abstract][Full Text] [Related]
35. The BCL11 gene family: involvement of BCL11A in lymphoid malignancies.
Satterwhite E; Sonoki T; Willis TG; Harder L; Nowak R; Arriola EL; Liu H; Price HP; Gesk S; Steinemann D; Schlegelberger B; Oscier DG; Siebert R; Tucker PW; Dyer MJ
Blood; 2001 Dec; 98(12):3413-20. PubMed ID: 11719382
[TBL] [Abstract][Full Text] [Related]
36. Leukaemic non-Hodgkin's lymphomas with hyperdiploid cells and t(11;14)(q13;q32): a subtype of mantle cell lymphoma?
Daniel MT; Tigaud I; Flexor MA; Nogueira ME; Berger R; Jonveaux P
Br J Haematol; 1995 May; 90(1):77-84. PubMed ID: 7786799
[TBL] [Abstract][Full Text] [Related]
37. Primary cutaneous follicular lymphoma: an assessment of clinical, histopathologic, immunophenotypic, and molecular features.
Mirza I; Macpherson N; Paproski S; Gascoyne RD; Yang B; Finn WG; Hsi ED
J Clin Oncol; 2002 Feb; 20(3):647-55. PubMed ID: 11821444
[TBL] [Abstract][Full Text] [Related]
38. Characterization of IGH rearrangements in non-Hodgkin's B-cell lymphomas by fluorescence in situ hybridization.
Bernicot I; Douet-Guilbert N; Le Bris MJ; Morice P; Abgrall JF; Berthou C; Morel F; De Braekeleer M
Anticancer Res; 2005; 25(5):3179-82. PubMed ID: 16101124
[TBL] [Abstract][Full Text] [Related]
39. Detection of t(12;14)(p13;q32) in a patient with IGH-CCND1 negative mantle cell lymphoma resembling ultra-high risk chronic lymphocytic leukemia.
Miao Y; Wang R; Fan L; Qiu H; Wu Y; Chen Y; Xu W; Li J
Int J Clin Exp Pathol; 2015; 8(6):7494-8. PubMed ID: 26261659
[TBL] [Abstract][Full Text] [Related]
40. Alternative translocation breakpoint cluster region 5' to BCL-6 in B-cell non-Hodgkin's lymphoma.
Butler MP; Iida S; Capello D; Rossi D; Rao PH; Nallasivam P; Louie DC; Chaganti S; Au T; Gascoyne RD; Gaidano G; Chaganti RS; Dalla-Favera R
Cancer Res; 2002 Jul; 62(14):4089-94. PubMed ID: 12124346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]